Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $831.8400 (-0.63%) ($826.0300 - $840.0450) on Mon. Oct. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.19% (three month average) | RSI | 46 | Latest Price | $831.8400(-0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(61%) DIA(56%) XLF(56%) SPY(53%) | Factors Impacting REGN price | REGN will decline at least -0.595% in a week (0% probabilities). VXX(-47%) VIXM(-41%) TBT(-25%) USO(-20%) GLD(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.595% (StdDev 1.19%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $824.71(0.86%) | 10 Day Moving Average | $826.51(0.64%) | 20 Day Moving Average | $827.71(0.5%) | To recent high | -1.5% | To recent low | 18.5% | Market Cap | $88.199b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |